| Company Name: |
Beijing krre Technology Co., Ltd
|
| Tel: |
17710868586 |
| Email: |
991087253@qq.com |
| Products Intro: |
Product Name:Fmoc-Thr((Ac4Galβ1-3)Me,Ac4Neu5Acα2-6AcGalNAcα)-OH
CAS:174783-92-7
Purity:95% Package:100mg ;500mg ；1g;5g；25g;100g
|
| Company Name: |
Xi'an Kaixin Biotechnology Co., Ltd
|
| Tel: |
029-68881181 13619217766 |
| Email: |
3495811982@qq.com |
| Products Intro: |
Product Name:Fmoc-Thr((Ac4Galβ1-3)Me,Ac4Neu5Acα2-6AcGalNAcα)-OH
CAS:174783-92-7
Purity:95%+ Package:1g;5g;10g
|
| Company Name: |
WEITIXIHAUGONG
|
| Tel: |
0371-53370800 18037197114 |
| Email: |
2853031799@qq.com |
| Products Intro: |
Product Name:Fmoc-Thr((Ac4Galβ1-3)Me,Ac4Neu5Acα2-6AcGalNAcα)-OH
CAS:174783-92-7
Purity:98% Package:1g;5g;25g
|
| Company Name: |
ShenZhen Trendseen Biological Technology Co.,Ltd.
|
| Tel: |
13417589054 13417589054 |
| Email: |
trendseenbio@gmail.com |
| Products Intro: |
Product Name:Fmoc-Thr((Ac4Galβ1-3)Me,Ac4Neu5Acα2-6AcGalNAcα)-OH
CAS:174783-92-7
Purity:>=98% Package:1g; 10g
|
| Company Name: |
yaoyangpharm
|
| Tel: |
17739007752 17324281842 |
| Email: |
m1773900775@163.com |
| Products Intro: |
Product Name:Fmoc-Thr((Ac4Galβ1-3)Me,Ac4Neu5Acα2-6AcGalNAcα)-OH
CAS:174783-92-7
|
|
| | Fmoc-Thr((Ac4Galβ1-3)Me,Ac4Neu5Acα2-6AcGalNAcα)-OH Basic information |
| Product Name: | Fmoc-Thr((Ac4Galβ1-3)Me,Ac4Neu5Acα2-6AcGalNAcα)-OH | | Synonyms: | Fmoc-Thr((Ac4Galβ1-3)Me,Ac4Neu5Acα2-6AcGalNAcα)-OH;L-Threonine, O-[O-(N-acetyl-4,7,8,9-tetra-O-acetyl-1-methyl-β-neuraminosyl)-(2→6)-O-[2,3,4,6-tetra-O-acetyl-β-D-galactopyranosyl-(1→3)]-4-O-acetyl-2-(acetylamino)-2-deoxy-α-D-galactopyranosyl]-N-[(9H-fluoren-9-ylmethoxy)carbonyl]- (9CI) | | CAS: | 174783-92-7 | | MF: | C63H79N3O32 | | MW: | 1390.3 | | EINECS: | | | Product Categories: | | | Mol File: | Mol File | ![Fmoc-Thr((Ac4Galβ1-3)Me,Ac4Neu5Acα2-6AcGalNAcα)-OH Structure]() |
| | Fmoc-Thr((Ac4Galβ1-3)Me,Ac4Neu5Acα2-6AcGalNAcα)-OH Chemical Properties |
| Boiling point | 1221.9±65.0 °C(Predicted) | | density | 1.42±0.1 g/cm3(Predicted) | | pka | 3.32±0.10(Predicted) |
| | Fmoc-Thr((Ac4Galβ1-3)Me,Ac4Neu5Acα2-6AcGalNAcα)-OH Usage And Synthesis |
| | Fmoc-Thr((Ac4Galβ1-3)Me,Ac4Neu5Acα2-6AcGalNAcα)-OH Preparation Products And Raw materials |
|